| Literature DB >> 35019121 |
Luciano Hybner1,2, Fernando Issamu Tabushi1, Luis Martins Collaço1,3, Érika Gomes DA Rosa1, Bruno de Faria Melquíades DA Rocha1, Mateus Franzoni Bochnia1.
Abstract
BACKGROUND: Retrograde endoscopic cholangiopancreatography (ERCP) effectively treats biliary and pancreatic disorders. Its indications are limited and precise, since its misuse delays adequate treatment, increases costs and to patient´s adverse events. AIM: To compare clinical, radiological and exploratory characteristics in relation to therapeutic success in patients undergoing ERCP in relation to age.Entities:
Mesh:
Year: 2022 PMID: 35019121 PMCID: PMC8735269 DOI: 10.1590/0102-672020210003e1607
Source DB: PubMed Journal: Arq Bras Cir Dig ISSN: 0102-6720
FIGURE 1Single stone choledocholithiasis visualized by ERCP in the distal portion
Pre-ERCP characteristics
| Indications | Group 1 | Group 2 | p |
|---|---|---|---|
| Sex F/M | 114/63 | 121/114 | 0.009 |
| Therapeutics/diagnosis | 171(96.6%) / 6 (3.4%) | 232 (98.7%) / 3 (1.3%) | 0.181 |
| Urgency/elective | 21 (11.9%) / 156 (88.1%) | 21 (11.9%) / 156 (88.1%) | 0.042 |
Indications for carrying out the ERCP
| Most frequent indications | Group 1 | Group 2 | p |
|---|---|---|---|
| Choledocolithiasis | 107 (60.5%) | 107 (45.5%) | 0.003 |
| Obstructive jaundice | 18 (10.2%) | 26 (11.1%) | 0.771 |
| Benign stenosis | 16 (9%) | 14 (6.0%) | 0.999 |
| Acute pancreatitis | 16 (9%) | 13 (5.5%) | 0.168 |
| Cholangiocarcinoma | 5 (2.8%) | 10 (4.3%) | 0.443 |
| Acute cholangitis | 4 (2.3%) | 26 (11.1%) | 0.001 |
| Fistula | 4 (2.3%) | 0 | 0.033 |
| Papilla neoplasm | 3 (1.7%) | 13 (5.5%) | 0.046 |
| Malignant stenosis | 3 (1.7%) | 23 (9.8%) | 0.002 |
| Chronic pancreatitis | 2 (1.1%) | 2 (0.9%) | 0.999 |
Radiological presentation during the procedure
| Group 1 | Group 2 | p | |
|---|---|---|---|
| Calculi | 121 (72.5%) | 133 (63.9%) | p=0.08 |
| Dilated bile duct | 52 (31%) | 129 (57.1%) | p<0.001 |
| Stenosis | 28 (16.7%) | 62 (29.4%) | p=0.004 |
CPRE results
| Group 1 | Group 2 | p | |
|---|---|---|---|
| Catheterization success | 168 (94.9%) | 210 (89.4%) | p=0.043 |
| Bile duct clearing | 162 (91.5%) | 196 (83.4%) | p=0.016 |
Procedures performed
| Group 1 | Group 2 | p | |
|---|---|---|---|
| Papillectomy | 3 (1.7%) | 4 (1.8%) | p>0.999 |
| Plastic prosthesis | 30 (16.9%) | 68 (30.4%) | p=0.001 |
| Metal prosthesis | 4 (2.3%) | 12 (5.4%) | p=0.001 |